Advertisement

Human B-Cell Growth and Differentiation Factors, and Their Effects on Leukemic B-Cells

  • F. C. Rawle
  • R. J. Armitage
  • P. C. L. Beverley
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 31)

Abstract

A wealth of data on B-cell growth and differentiation factors has been published recently, and so many different factors have been shown to act on B cells [1] that it is difficult to determine which, if any, of these factors are physiologically relevant. Initial models assumed that B-cell activation leads to an ordered expression of receptors for specific growth and then differentiation factors, but these now appear to be incorrect. Firstly, most of the factors with functional effects on B cells are not specific for cells of that lineage. IL2, IL1 and IFNγ have all been shown to have effects on B cells [1, 2]. Secondly, BSF-2 (B-cell differentiation factor BCDFγ), which has recently been cloned [3], has been shown to activate mast cells and basophils, and to cause T-cell proliferation [4], while BCGF II acts as a differentiation factor for eosinophils [5].

Keywords

Chronic Lymphocytic Leukaemia Bladder Carcinoma Chronic Lymphocytic Leukaemia Cell Activate Mast Cell Mixed Lymphocyte Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kishimoto T (1985) Annu Rev Immunol 3:135–159CrossRefGoogle Scholar
  2. 2.
    Melchers F, Anderson J (1984) Cell 37:715–720CrossRefGoogle Scholar
  3. 3.
    Noma Y, Sideras P, Naito T, Bergstedt-Lindquist S, Azuma C, Severinson E, Tanabe T et al. (1986) Nature 319:640–646PubMedCrossRefGoogle Scholar
  4. 4.
    Vitetta E (in press) Proceedings of the International Conference on Lymphocyte Activation and Immune RegulationGoogle Scholar
  5. 5.
    Sanderson CJ, O’Garra A, Warren DJ, Klaus GGB (1986) Proc Natl Acad Sci USA 83:437–440PubMedCrossRefGoogle Scholar
  6. 6.
    Muraguchi A, Kishimoto T, Miki Y, Kuritani T, Kaieda T, Yoshizaki K, Yamamura Y (1981) J Immunol 127:412–416PubMedGoogle Scholar
  7. 7.
    Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun H, Kishimoto T (1985) Proc Natl Acad Sci USA 82:5490–5494PubMedCrossRefGoogle Scholar
  8. 8.
    Golay JT, Rawle FC, Beverley PCL (1985) In: Reinherz EL, Nadler LM (eds) Leucocyte typing II. Springer, Berlin Heidelberg New York Tokyo, pp 463–472Google Scholar
  9. 9.
    Golay JT, Clark EA, Beverley PCL (1985) J Immunol 135:3795–3801PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • F. C. Rawle
    • 1
    • 2
  • R. J. Armitage
    • 1
  • P. C. L. Beverley
    • 1
  1. 1.ICRF Human Tumour Immunology Group, Faculty of Clinical SciencesUniversity College LondonLondonUK
  2. 2.Department of Zoology and Comparative AnatomyUniversity College LondonLondonUK

Personalised recommendations